WINDTREE THERAPEUTICS INC /DE/ Cash and Restricted Cash
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Cash and Restricted Cash of $17.08 million as of 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2021-03-29
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $17.08M.
- 2020-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.95M.
- 2019-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22.73M.
- 2019-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.59M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2020-12-31 | $17.08M 10-K · filed 2021-03-29 |
| 2020-03-31 | $16.95M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $22.73M 10-K · filed 2021-03-29 |
| 2019-09-30 | $4.59M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $6.28M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.22M 10-Q · filed 2020-05-13 |
| 2018-12-31 | $11.36M 10-K · filed 2021-03-29 |
| 2018-09-30 | $780.00K 10-Q · filed 2019-11-14 |
| 2018-06-30 | $778.00K 10-Q · filed 2019-08-14 |
| 2018-03-31 | $1.99M 10-Q · filed 2019-05-20 |
| 2017-12-31 | $2.04M 10-K · filed 2020-04-03 |
| 2017-09-30 | $1.98M 10-Q · filed 2018-11-14 |
| 2017-06-30 | $2.75M 10-Q · filed 2018-08-14 |
| 2017-03-31 | $8.25M 10-Q · filed 2018-05-21 |
| 2016-12-31 | $5.81M 10-K/A · filed 2019-04-23 |
| 2016-09-30 | $12.61M 10-Q · filed 2017-11-14 |
| 2016-06-30 | $20.55M 10-Q · filed 2017-08-21 |
| 2016-03-31 | $29.63M 10-Q · filed 2017-05-15 |
| 2015-12-31 | $38.95M 10-K · filed 2018-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |